A suite of mathematical solutions to describe ternary complex formation and their application to targeted protein degradation by heterobifunctional ligands

被引:39
作者
Han, Bomie [1 ]
机构
[1] Eli Lilly & Co, Dept Mol Pharmacol, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA
关键词
targeted protein degradation; ternary complex; PROTAC; cooperativity; protein degradation; mathematical modeling; molecular pharmacology; kinetics; E3 ubiquitin ligase; drug development; chemical biology; computational biology; heterobifunctional ligand; E3 UBIQUITIN LIGASE; SELECTIVE DEGRADATION; STRUCTURAL BASIS; SMALL MOLECULES; INHIBITION; KNOCKDOWN; CEREBLON; OPTIMIZATION; PROTACS; DESIGN;
D O I
10.1074/jbc.RA120.014715
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Small molecule-induced targeted protein degradation by heterobifunctional ligands or molecular glues represents a new modality in drug development, allowing development of therapeutic agents for targets previously considered undruggable. Successful target engagement requires the formation of a ternary complex (TC) when the ligand brings its target protein in contact with an E3 ubiquitin ligase. Unlike traditional drugs, where target engagement can be described by a simple bimolecular equilibrium equation, similar mathematical tools are currently not available to describe TC formation in a universal manner. This current limitation substantially increases the challenges of developing drugs with targeted protein degradation mechanism. In this article, I provide a full, exact, and universal mathematical description of the TC system at equilibrium for the first time. I have also constructed a comprehensive suite of mathematical tools for quantitative measurement of target engagement and equilibrium constants from experimental data. Mechanistic explanations are provided for many common challenges associated with developing this type of therapeutic agent. Insights from these analyses provide testable hypotheses and grant direction to drug development efforts in this promising area. The mathematical and analytical tools described in this article may also have broader applications in other areas of biology and chemistry in which ternary complexes are observed.
引用
收藏
页码:15280 / 15291
页数:12
相关论文
共 43 条
[1]   Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs [J].
An, Sainan ;
Fu, Liwu .
EBIOMEDICINE, 2018, 36 :553-562
[2]  
Bondeson DP, 2015, NAT CHEM BIOL, V11, P611, DOI [10.1038/NCHEMBIO.1858, 10.1038/nchembio.1858]
[3]   HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of Halo Tag Fusion Proteins [J].
Buckley, Dennis L. ;
Raina, Kanak ;
Darricarrere, Nicole ;
Hines, John ;
Gustafson, Jeffrey L. ;
Smith, Ian E. ;
Miah, Aija H. ;
Harling, John D. ;
Crews, Craig M. .
ACS CHEMICAL BIOLOGY, 2015, 10 (08) :1831-1837
[4]   Targeting the von Hippel-Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α Interaction [J].
Buckley, Dennis L. ;
Van Molle, Inge ;
Gareiss, Peter C. ;
Tae, Hyun Seop ;
Michel, Julien ;
Noblin, Devin J. ;
Jorgensen, William L. ;
Ciulli, Alessio ;
Crews, Craig M. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2012, 134 (10) :4465-4468
[5]   The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study [J].
Burslem, George M. ;
Smith, Blake E. ;
Lai, Ashton C. ;
Jaime-Figueroa, Saul ;
McQuaid, Daniel C. ;
Bondeson, Daniel P. ;
Toure, Momar ;
Dong, Hanqing ;
Qian, Yimin ;
Wang, Jing ;
Crew, Andrew P. ;
Hines, John ;
Crews, Craig M. .
CELL CHEMICAL BIOLOGY, 2018, 25 (01) :67-+
[6]   A MULTIUBIQUITIN CHAIN IS CONFINED TO SPECIFIC LYSINE IN A TARGETED SHORT-LIVED PROTEIN [J].
CHAU, V ;
TOBIAS, JW ;
BACHMAIR, A ;
MARRIOTT, D ;
ECKER, DJ ;
GONDA, DK ;
VARSHAVSKY, A .
SCIENCE, 1989, 243 (4898) :1576-1583
[7]   Inducing protein-protein interactions with molecular glues [J].
Che, Ye ;
Gilbert, Adam M. ;
Shanmugasundaram, Veerabahu ;
Noe, Mark C. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (15) :2585-2592
[8]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[9]   RING Domain E3 Ubiquitin Ligases [J].
Deshaies, Raymond J. ;
Joazeiro, Claudio A. P. .
ANNUAL REVIEW OF BIOCHEMISTRY, 2009, 78 :399-434
[10]   Regulation of Raf-1 activation and signalling by dephosphorylation [J].
Dhillon, AS ;
Meikle, S ;
Yazici, Z ;
Eulitz, M ;
Kolch, W .
EMBO JOURNAL, 2002, 21 (1-2) :64-71